(Q43268894)
Statements
Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study (English)
K Zhou
L Donnelly
L Burch
R Tavendale
G Leese
A T Hattersley
30 September 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference